In this On-demand webinar, we discuss key considerations for driving our function forward on impact, initiating conversations on impact, and practical considerations for improving the evaluation of impact.
This session examines how integrating behavioral science insights (how humans make decisions and what drives their behavior) and adult education best practices (how adults best acquire, retain, and use knowledge) can evolve external medical education from knowledge dissemination alone to behavioral understanding and, ultimately, impactful outcomes.
This Standard and Guidance is intended to inform the framework in Strategy to help provide Medical Affairs professionals with practical tools for planning, executing, and evaluating Measuring Value and Impact in Medical Affairs.
The objective of this White Paper is to guide Medical Affairs personnel on the key components of the legal, regulatory, and industry codes of practice requirements which are applicable to Medical Affairs in Pharma and Medical Devices industries, and how to identify and mitigate risks. This paper also includes company control frameworks for compliance with the requirements through policies, processes (usually captured in Standard Operating Procedures [SOPs]), systems, training, monitoring, and audit.
In this on-demand webinar, we will discuss how to develop a customer-centric engagement strategy leveraging an omnichannel approach.
In this webinar, we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study.
This series of the Elevate Podcast illuminates how AI and Generative AI seem to be a part of every webinar, conference, and conversation these days. This podcast will explore three proof-of-concept (POC) use cases from recent work in the field of Medical Information.
In this forum, we will share traditional medical insights with the innovative world of omnichannel strategies.
In this webinar, we will discuss the regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.
Join the MAPS Germany Chapter for an Engaging Virtual Event,
“Making Generative AI Work for You: A Medical Affairs Roadmap from Ideation to Execution” (Part 2). Discover how Generative AI is revolutionising Medical Affairs!